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Introduction
Infection of transvenous cardiac implantable electronic de-
vices (CIEDs) are a serious complication with high morbidity
andmortality.1 Even though complete device and lead extrac-
tion is mandatory and recommended with a class I indication
in current guidelines,2 the decision of the type of intervention
in case of large vegetations (eg, transvenous vs open surgical
lead extraction) remains challenging. While a vegetation size
.20 mm is a cut-off parameter to consider open surgical
extraction according to the recent ESC/EACTS guidelines2
(class IIb), smaller vegetations may be treated by transvenous
lead extraction. However, in this context, it remains unclear
why despite successful transvenous lead extraction and anti-
biotic treatment, the 1-year mortality remains high at 30% ac-
cording to the European ELECTRA registry.1 A closer look
into the cause of death in this population reveals that nearly
50% of these patients die owing to ongoing sepsis. Since pul-
monary embolization of vegetations during lead extraction
may be the reason for this observation, various interventional
techniques to reduce the size of vegetations have been eval-
uated, including the use of basket catheters for “vegectomy”3
or systemic thrombolysis.4 A transcatheter aspiration system
based on an extracorporeal circuit in a venovenous configu-
ration (AngioVac; Angiodynamics, Latham, NY) using a
specialized filter has recently been introduced and is success-
fully used in an increasing number of patients.5However, this
system has limitations such as need for therapeutic anticoa-
gulation during the procedure and high healthcare costs.
We herein describe the case of a patient suffering from
CIED-related infection treated interventionally using a new
concept.
Case report
A 55-year-old man with a dual-chamber pacemaker im-
planted 6 months ago was referred to our center owing to
Staphylococcus aureus bacteremia. Transthoracic echocardi-
ography confirmed the presence of a mobile, 10 ! 12 mm
mass attached to the ventricular lead located within the right
atrium. A preinterventional venogram demonstrated
occluded left subclavian and axillary veins. Because of this
finding as well as the size of the vegetation, increased risk
of pulmonary embolization of the vegetation during lead
explantation was present, and we decided to change the con-
ventional explantation approach. Via a right femoral venous
access, a 27F sheath normally used for leadless pacemaker
implantation (Micra TPS introducer sheath; Medtronic, Min-
neapolis, MN) was advanced to the low right atrium
(Figure 1). The atrial lead could be explanted with simple
traction from the infraclavicular pocket. Similarly, the ven-
tricular lead was detached from the right ventricle and pulled
back so that the distal end was free-floating within the right
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Figure 1 Snaring of the permanent pacemaker lead using a gooseneck snare introduced through the femoral introducer sheath.
Figure 2 The lead is being explanted with simple traction via the femoral introducer sheath.
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atrium. Through the 27F sheath, a 20 mm gooseneck snare
was introduced and the distal end of the lead snared
(Figure 1). The lead was cut at the proximal part within the
infraclavicular pocket and pulled into the large femoral
sheath (Figure 2). As soon as the lead was completely within
the sheath, the entire unit (sheath with the inside lead) was
removed from the patient’s body. On the operating table
outside the patient’s body, the lead was removed from the
sheath and the large vegetation could be seen still attached
to the lead (Figure 3).
Discussion
Complete removal of the device system, including the vege-
tation, is mandatory for successful treatment of infected
CIEDs.1,2 The larger the vegetation, the more likely is the
Figure 3 Explanted lead including the attached bacterial vegetation.
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need for open surgical extraction, especially in vegetations
larger than 20 mm2. However, the majority of infected
mass may not reach this cut-off, indicating that a relevant
portion of the affected patients will still undergo transvenous
lead extraction.6 In order to avoid the use of a transvenous
aspiration system we employed a large-sized sheath to pre-
vent potential vegetation embolization. The Micra TPS
introducer sheath (Medtronic) has been safely used in
contemporary implantation of leadless pacemaker7 in more
than 50,000 patients worldwide so far and is most likely
large enough to be able to surround both the lead and the
vegetation of this size during lead explantation from the
groin, therefore facilitating successful explantation. Indeed,
it has been used for this purpose by others but, according to
our knowledge, not yet with such a large vegetation.8 We
herein demonstrate that this approach may offer a very
safe option for lead and vegetation extraction. A limitation
of this case is the short lead dwell time of only 8 months
simplifying the procedure. In different clinical situations
with a longer dwell time it could be necessary to use a steer-
able sheath in addition to facilitate successful snaring of the
lead, but using such a usually smaller-diameter tool
(compared to the larger Micra TPS introducer sheath) as
an outer sheath over the electrode may increase the risk for
vegetation embolization. In such a scenario, it can be recom-
mended to still use a steerable sheath (through theMicra TPS
introducer sheath) to snare the lead or lead fragment. For the
extraction itself, the larger Micra TPS introducer sheath
should then be railed and advanced over the steerable sheath
up to the distal end of the electrode as demonstrated by
Gabriels and colleagues.8
In summary, the use of the Micra TPS introducer sheath as
a femoral workstation offers an additional option during lead
extraction. Whether this approach is similarly safe for all
leads (independently of the lead dwell time) and/or up to
which vegetation size will require further work.
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